Transcriptome analysis reveals the effect of propyl gallate on kiwifruit callus formation.

KEY MESSAGE: Exploring the potential action mechanisms of reactive oxygen species during the callus inducing, they can activate specific metabolic pathways in explants to regulate callus development. Reactive oxygen species (ROS) play an important role in the regulation of plant growth and development, but the mechanism of their action on plant callus formation remains to be elucidated. To address this question, kiwifruit was selected as the explant for callus induction, and the influence of ROS on callus formation was investigated by introducing propyl gallate (PG) as an antioxidant into the medium used for inducing callus. The results have unveiled that the inclusion of PG in the medium has disturbed the equilibrium of ROS during the formation of the kiwifruit callus. We selected the callus that was induced by the addition of 0.05 mmol/L PG to the MS medium. The callus exhibited a significant difference in the amount compared to the control medium without PG. The callus induced by the MS medium without PG was used as the control for comparison. KEGG enrichment indicated that PG exposure resulted in significant differences in gene expression in related pathways, such as phytohormone signaling and glutathione in kiwifruit callus. Weighted gene co-expression analysis indicated that the pertinent regulatory networks of both ROS and phytohormone signaling were critical for the establishment of callus in kiwifruit leaves. In addition, during the process of callus establishment, the ROS level of the explants was also closely related to the genes for transmembrane transport of substances, cell wall formation, and plant organ establishment. This investigation expands the theory of ROS-regulated callus formation and presents a new concept for the expeditious propagation of callus in kiwifruit.

Propyl gallate induces human pulmonary fibroblast cell death through the regulation of Bax and caspase-3.

Propyl gallate (PG) has been found to exert an inhibitory effect on the growth of different cell types, including lung cancer cells. However, little is known about the cytotoxicological effects of PG specifically on normal primary lung cells. The current study examined the cellular effects and cell death resulting from PG treatment in human pulmonary fibroblast (HPF) cells. DNA flow cytometry results demonstrated that PG (100-1,600 µM) had a significant impact on the cell cycle, leading to G1 phase arrest. Notably, 1,600 µM PG slightly increased the number of sub-G1 cells. Additionally, PG (400-1,600 µM) resulted in the initiation of cell death, a process that coincided with a loss of mitochondrial membrane potential (MMP; ΔΨm). This loss of MMP (ΔΨm) was evaluated using a FACS cytometer. In PG-treated HPF cells, inhibitors targeting pan-caspase, caspase-3, caspase-8, and caspase-9 showed no significant impact on the quantity of annexin V-positive and MMP (ΔΨm) loss cells. The administration of siRNA targeting Bax or caspase-3 demonstrated a significant attenuation of PG-induced cell death in HPF cells. However, the use of siRNAs targeting p53, Bcl-2, or caspase-8 did not exhibit any notable effect on cell death. Furthermore, none of the tested MAPK inhibitors, including MEK, c-Jun N-terminal kinase (JNK), and p38, showed any impact on PG-induced cell death or the loss of MMP (ΔΨm) in HPF cells. In conclusion, PG induces G1 phase arrest of the cell cycle and cell death in HPF cells through apoptosis and/or necrosis. The observed HPF cell death is mediated by the modulation of Bax and caspase-3. These findings offer insights into the cytotoxic and molecular effects of PG on normal HPF cells.